Cargando…
Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men
African American men have higher incidence rates of aggressive prostate cancer, where high levels of calcium and serum vitamin D deficient levels play a role in the racial differences in incidence. In this study, we examined associations of serum vitamin D with aggressive prostate cancer to improve...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295056/ https://www.ncbi.nlm.nih.gov/pubmed/28036013 http://dx.doi.org/10.3390/nu9010012 |
_version_ | 1782505356152274944 |
---|---|
author | Nelson, Shakira M. Batai, Ken Ahaghotu, Chiledum Agurs-Collins, Tanya Kittles, Rick A. |
author_facet | Nelson, Shakira M. Batai, Ken Ahaghotu, Chiledum Agurs-Collins, Tanya Kittles, Rick A. |
author_sort | Nelson, Shakira M. |
collection | PubMed |
description | African American men have higher incidence rates of aggressive prostate cancer, where high levels of calcium and serum vitamin D deficient levels play a role in the racial differences in incidence. In this study, we examined associations of serum vitamin D with aggressive prostate cancer to improve our understanding of higher susceptibility of aggressive disease in this racial cohort. From Howard University Hospital, 155 African American men with clinically-identified prostate cancer were identified; 46 aggressive cases, and 58 non-aggressive cases. Serum vitamin D was assessed from fasting blood samples, and total calcium intake was assessed using the Block Food Frequency Questionnaire. Vitamin D receptor polymorphisms from three different loci were genotyped; rs731236, rs1544410, and rs11568820. Multivariate logistic regression models were used to determine odds ratios (OR) and 95% confidence intervals (CI) comparing aggressive to non-aggressive prostate cancer. Vitamin D deficiency (<20 ng/mL) significantly increased risk of aggressive disease (OR: 3.1, 95% CI: 1.03–9.57, p-value = 0.04). Stratification by total calcium showed high calcium levels (≥800 mg/day) modified this association (OR: 7.3, 95% CI: 2.15–47.68, p-interaction = 0.03). Genetic variant rs11568820 appeared to increase the magnitude of association between deficient serum vitamin D and aggressive prostate cancer (OR: 3.64, 95% CI: 1.12–11.75, p-value = 0.05). These findings suggest that high incidence of aggressive prostate cancer risk in African American men may be due in-part to deficient levels of serum vitamin D. Other factors, including genetics, should be considered for future studies. |
format | Online Article Text |
id | pubmed-5295056 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-52950562017-02-10 Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men Nelson, Shakira M. Batai, Ken Ahaghotu, Chiledum Agurs-Collins, Tanya Kittles, Rick A. Nutrients Article African American men have higher incidence rates of aggressive prostate cancer, where high levels of calcium and serum vitamin D deficient levels play a role in the racial differences in incidence. In this study, we examined associations of serum vitamin D with aggressive prostate cancer to improve our understanding of higher susceptibility of aggressive disease in this racial cohort. From Howard University Hospital, 155 African American men with clinically-identified prostate cancer were identified; 46 aggressive cases, and 58 non-aggressive cases. Serum vitamin D was assessed from fasting blood samples, and total calcium intake was assessed using the Block Food Frequency Questionnaire. Vitamin D receptor polymorphisms from three different loci were genotyped; rs731236, rs1544410, and rs11568820. Multivariate logistic regression models were used to determine odds ratios (OR) and 95% confidence intervals (CI) comparing aggressive to non-aggressive prostate cancer. Vitamin D deficiency (<20 ng/mL) significantly increased risk of aggressive disease (OR: 3.1, 95% CI: 1.03–9.57, p-value = 0.04). Stratification by total calcium showed high calcium levels (≥800 mg/day) modified this association (OR: 7.3, 95% CI: 2.15–47.68, p-interaction = 0.03). Genetic variant rs11568820 appeared to increase the magnitude of association between deficient serum vitamin D and aggressive prostate cancer (OR: 3.64, 95% CI: 1.12–11.75, p-value = 0.05). These findings suggest that high incidence of aggressive prostate cancer risk in African American men may be due in-part to deficient levels of serum vitamin D. Other factors, including genetics, should be considered for future studies. MDPI 2016-12-28 /pmc/articles/PMC5295056/ /pubmed/28036013 http://dx.doi.org/10.3390/nu9010012 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nelson, Shakira M. Batai, Ken Ahaghotu, Chiledum Agurs-Collins, Tanya Kittles, Rick A. Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men |
title | Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men |
title_full | Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men |
title_fullStr | Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men |
title_full_unstemmed | Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men |
title_short | Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men |
title_sort | association between serum 25-hydroxy-vitamin d and aggressive prostate cancer in african american men |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295056/ https://www.ncbi.nlm.nih.gov/pubmed/28036013 http://dx.doi.org/10.3390/nu9010012 |
work_keys_str_mv | AT nelsonshakiram associationbetweenserum25hydroxyvitamindandaggressiveprostatecancerinafricanamericanmen AT bataiken associationbetweenserum25hydroxyvitamindandaggressiveprostatecancerinafricanamericanmen AT ahaghotuchiledum associationbetweenserum25hydroxyvitamindandaggressiveprostatecancerinafricanamericanmen AT agurscollinstanya associationbetweenserum25hydroxyvitamindandaggressiveprostatecancerinafricanamericanmen AT kittlesricka associationbetweenserum25hydroxyvitamindandaggressiveprostatecancerinafricanamericanmen |